as memory serves it was only a couple of years ago that Prana was looking for a partner to help fund the further dog studies needed to get the planned phase 3 trial up and running for Huntingtons disease. Professor Shoulson is still involved with the company and it would be interesting to know what he thinks about running a phase 3 trial on pbt2 considering that he was previously very keen on the idea
PBT Price at posting:
4.9¢ Sentiment: Hold Disclosure: Held
